6533b858fe1ef96bd12b6575

RESEARCH PRODUCT

Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 772 patients

Alessandro ConsolaroRomina GallizziDonato RiganteFrancesco La TorreAlma Nunzia OlivieriMaria Cristina MaggioAdele CivinoAngelo RavelliAntonella InsalacoAlberto MartiniLuciana BredaSara VerazzaLoredana LeporeCristina RobbianoRolando CimazGiovanni ContiMg AlpigianiPatrizia BaroneGianfranco D'angeloFabrizia CoronaRita Consolini

subject

juvenile idiopathic arthritis etanerceptmedicine.medical_specialtyPediatricsbusiness.industryAlternative medicineArthritismedicine.diseaseRheumatologyEtanerceptDisease courseSettore MED/38 - Pediatria Generale E SpecialisticaRheumatologyInternal medicinePoster PresentationPediatrics Perinatology and Child HealthPhysical therapymedicineImmunology and AllergyJuvenilePediatrics Perinatology and Child Healthbusinessmedicine.drug

description

The advent of biologic medications has considerably increased the potential for treatment benefit in juvenile idiopathic arthritis (JIA), with clinical remission being now achievable in a substantial proportion of patients.

yearjournalcountryeditionlanguage
2014-09-01
http://hdl.handle.net/10447/98577